Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70179 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Sidra A Ali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Blood Platelets. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, ACT Health, International Society on Thrombosis and Haemostasis.
Abstract (Originalsprache)
Patients with immune thrombocytopenia (ITP) remain a challenge to diagnose, manage and predict bleeding risk. A comprehensive assessment of platelet function may aid clinical management. This study assessed platelet parameters to predict bleeding in ITP. Blood from 103 clinically annotated cases with isolated thrombocytopenia and 123 healthy donors was evaluated. In the ITP cohort, 75/110 encounters (68%) had platelet counts below 50 × 10 9 /L. Platelet surface proteins, reticulated platelets and activation were quantified using flow cytometry. Soluble receptor fragments, citrullinated histone‐DNA (CitH3‐DNA) complexes and thrombopoietin (TPO) were quantified by enzyme‐linked immunosorbent assay (ELISA). Whole blood clotting and platelet contribution to clot formation were evaluated using viscoelastography. Elevated levels of glycoprotein (GP) VI ( p = 0.0012), Trem‐like transcript‐1 (TLT‐1) ( p = 0.0248), platelet‐bound immunoglobulin (Ig) G ( p < 0.0029), CitH3‐DNA complexes ( p = 0.0022), TPO ( p < 0.0001) and reduced platelet contribution to clot formation ( p < 0.0001) were observed in primary ITP patients with bleeding and bruising symptoms. A multivariable analysis revealed that measuring platelet indices strengthened a predictive bleeding model over platelet count alone (78.1% vs. 70.48%). Symptomatic ITP patients have measurable platelet dysfunction and quantifiable differences on platelet surface, increased evidence of NETosis and elevated TPO levels. Identifying biomarkers for ITP outcomes can define subsets of disease with clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
- Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
- The National Platelet Research and Referral Centre, Canberra, Australian Capital Territory, Australia.
- Haematology Department, the Canberra Hospital, Woden, Canberra, Australia.
ORCID-Profile: Sidra A Ali, Sarah M Hicks, Lucy A Coupland, Simone A Brysland, Vijay Bhoopalan, Yee Lin Thong, Amandeep Kaur, Robert K Andrews, Elizabeth E Gardiner, Philip Y-I Choi
Förderung
- National Health and Medical Research Council
- ACT Health
- International Society on Thrombosis and Haemostasis
- National Blood Authority
Zitieren
APA
Ali, S. A., Hicks, S. M., Coupland, L. A., Brysland, S. A., Bhoopalan, V., Thong, Y. L., Kaur, A., Andrews, R. K., Gardiner, E. E., & Choi, P. Y. (2026). Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes. British Journal of Haematology. https://doi.org/10.1111/bjh.70179
Vancouver
Ali SA, Hicks SM, Coupland LA, Brysland SA, Bhoopalan V, Thong YL, et al. Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes. British Journal of Haematology. 2026. doi:10.1111/bjh.70179
BibTeX
@article{Ali2026,
author = {Ali, Sidra A and Hicks, Sarah M and Coupland, Lucy A and Brysland, Simone A and Bhoopalan, Vijay and Thong, Yee Lin and Kaur, Amandeep and Andrews, Robert K and Gardiner, Elizabeth E and Choi, Philip Y-I},
title = {Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70179}
}
EUVIMED